| Meghan A. Wheeler-beachel, D.d.s., P.l.l.c. | |
|
3352 Brown Rd Caledonia NY 14423-9534 | |
| (585) 538-4500 | |
| Not Available |
| Full Name | Meghan A. Wheeler-beachel, D.d.s., P.l.l.c. |
|---|---|
| Speciality | Clinic/center - Dental |
| Location | 3352 Brown Rd, Caledonia, New York |
| Authorized Official Name and Position | Meghan Wheeler-beachel (DENTIST, OWNER) |
| Authorized Official Contact | 5855384500 |
| Accepts Medicare Insurance | This clinic does not participate in Medicare Program. |
| Mailing Address | Practice Location Address |
|---|---|
| Meghan A. Wheeler-beachel, D.d.s., P.l.l.c. 3352 Brown Rd Caledonia NY 14423-9534 Ph: (585) 538-4500 | Meghan A. Wheeler-beachel, D.d.s., P.l.l.c. 3352 Brown Rd Caledonia NY 14423-9534 Ph: (585) 538-4500 |
| NPI Number | 1306492590 |
|---|---|
| Provider Enumeration Date | 08/13/2019 |
| Last Update Date | 08/13/2019 |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1306492590 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 261QD0000X | Clinic/center - Dental | (* (Not Available)) | Primary |
News Archive
Results presented recently at the 6th Annual Conference of the International Society of Behavioural Nutrition and Physical Activity in Oslo, Norway, and soon to be published in the International Journal of Obesity reveal that 95 per cent of Australian adults are not meeting national physical activity and nutrition guidelines for health benefits.
Researchers for Peregrine Pharmaceuticals presented today at the Strategic Research Institute's Clinical-Stage Product Partnering Summit in La Jolla, CA a summary of clinical experience with Tumor Necrosis Therapy (TNT). The TNT technology is being developed in the U.S. and Europe by Peregrine under the trade name Cotara™. Over 200 patients have been treated with TNT world-wide and a TNT product has been approved to treat grade III or IV advanced lung cancer in the People's Republic of China. A Cotara registration study for brain cancer has been approved by the U.S. Food and Drug Administration, and a Phase I colorectal cancer study is on-going at Stanford University Medical Center.
A new study published in Scientific Reports, a Nature Research journal, shows how a one-time exposure during early pregnancy to cannabinoids (CBs) – both synthetic and natural – can cause growth issues in a developing embryo.
Technological advances are making the analysis of single bacterial infected human cells feasible, Würzburg researchers have used this technology to provide new insight into the Salmonella infection process.
A new study has shown that taking high-dose vitamin B supplements over a long period is associated with an increased risk of lung cancer among men.
› Verified 8 days ago